NEA Management Company as of June 30, 2022
Portfolio Holdings for NEA Management Company
NEA Management Company holds 57 positions in its portfolio as reported in the June 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Bright Health Group | 20.4 | $397M | 218M | 1.82 | |
Coursera (COUR) | 11.6 | $225M | 16M | 14.18 | |
Ionq Inc Pipe (IONQ) | 5.9 | $115M | 26M | 4.38 | |
Arcellx (ACLX) | 5.8 | $113M | 6.8M | 16.70 | |
Crispr Therapeutics Namen Akt (CRSP) | 5.0 | $97M | 1.6M | 60.77 | |
Cloudflare Cl A Com (NET) | 4.2 | $82M | 1.9M | 43.75 | |
Mirum Pharmaceuticals (MIRM) | 4.2 | $82M | 4.2M | 19.46 | |
Monte Rosa Therapeutics (GLUE) | 3.8 | $75M | 7.7M | 9.67 | |
Berkshire Grey Com Cl A | 2.8 | $55M | 38M | 1.45 | |
Cti Biopharma Corp Com New | 2.5 | $48M | 8.0M | 5.97 | |
Nkarta (NKTX) | 2.3 | $44M | 3.6M | 12.32 | |
Aurinia Pharmaceuticals (AUPH) | 2.0 | $40M | 4.0M | 10.05 | |
Savara (SVRA) | 1.9 | $37M | 24M | 1.52 | |
Trevi Therapeutics (TRVI) | 1.6 | $32M | 11M | 2.81 | |
Desktop Metal Com Cl A | 1.6 | $32M | 14M | 2.20 | |
Inventiva Sa Ads (IVA) | 1.6 | $32M | 5.6M | 5.67 | |
Adaptimmune Therapeutics Adr (ADAP) | 1.5 | $29M | 17M | 1.70 | |
Aveo Pharmaceuticals | 1.3 | $26M | 4.0M | 6.56 | |
Oyster Point Pharma | 1.3 | $26M | 5.9M | 4.33 | |
Geron Corporation (GERN) | 1.3 | $25M | 16M | 1.55 | |
Buzzfeed Cl A Com | 1.2 | $24M | 15M | 1.54 | |
Minerva Surgical | 1.2 | $24M | 10M | 2.35 | |
Verona Pharma Ads (VRNA) | 1.1 | $21M | 5.1M | 4.19 | |
Rhythm Pharmaceuticals (RYTM) | 1.0 | $20M | 4.9M | 4.15 | |
Akouos | 1.0 | $20M | 4.3M | 4.69 | |
Nextnav (NN) | 1.0 | $19M | 8.2M | 2.27 | |
Palo Alto Networks (PANW) | 0.8 | $15M | 33k | 469.23 | |
Vistagen Therapeutics | 0.7 | $14M | 16M | 0.88 | |
CVRX (CVRX) | 0.7 | $14M | 2.4M | 6.01 | |
Champions Oncology Com New (CSBR) | 0.7 | $14M | 1.7M | 8.00 | |
Satsuma Pharmaceuticals Ord | 0.7 | $13M | 3.1M | 4.14 | |
Reneo Pharmaceuticals (RPHM) | 0.7 | $13M | 4.8M | 2.65 | |
Affimed Therapeutics B V | 0.6 | $12M | 4.4M | 2.77 | |
Inozyme Pharma (INZY) | 0.5 | $11M | 2.4M | 4.29 | |
Metromile | 0.4 | $8.6M | 9.4M | 0.92 | |
Black Diamond Therapeutics (BDTX) | 0.4 | $8.5M | 3.4M | 2.46 | |
Global E Online SHS (GLBE) | 0.4 | $7.9M | 436k | 18.15 | |
Senti Biosciences Ord (SNTI) | 0.4 | $7.5M | 4.4M | 1.68 | |
Obseva Sa | 0.4 | $7.4M | 4.6M | 1.61 | |
Bill Com Holdings Ord (BILL) | 0.4 | $6.9M | 66k | 104.45 | |
Allakos (ALLK) | 0.3 | $6.8M | 2.2M | 3.13 | |
Glycomimetics (GLYC) | 0.3 | $5.4M | 9.1M | 0.60 | |
Mei Pharma Com New | 0.3 | $5.2M | 8.5M | 0.61 | |
Xeris Pharmaceuticals (XERS) | 0.3 | $5.0M | 3.2M | 1.54 | |
Synlogic | 0.2 | $4.9M | 4.2M | 1.15 | |
Airspan Networks Holdings (MIMOQ) | 0.2 | $4.6M | 1.5M | 2.99 | |
Lexicon Pharmaceuticals Com New (LXRX) | 0.2 | $4.4M | 2.4M | 1.86 | |
Phasebio Pharmaceuticals | 0.2 | $4.0M | 6.6M | 0.60 | |
Marker Therapeutics Ord | 0.2 | $3.5M | 11M | 0.33 | |
Eargo | 0.2 | $3.4M | 4.5M | 0.75 | |
Regulus Therapeutics Com New | 0.2 | $3.0M | 1.4M | 2.07 | |
Wheels Up Experience Com Cl A | 0.1 | $2.1M | 1.1M | 1.95 | |
Imara | 0.1 | $1.2M | 1.0M | 1.22 | |
Addex Therapeutics Sponsored Ads | 0.1 | $1.1M | 941k | 1.15 | |
Tracon Pharmaceuticals | 0.0 | $693k | 347k | 2.00 | |
Lumos Pharma (LUMO) | 0.0 | $503k | 65k | 7.69 | |
Akari Therapeutics Adr | 0.0 | $452k | 452k | 1.00 |